Citations (86)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Amelie Kinch, Eva Baecklund, Daniel Molin, Karlis Pauksens, Christer Sundström, Gunnar Tufveson & Gunilla Enblad. (2021) Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders. Acta Oncologica 60:6, pages 771-778.
Read now
Read now
Samuel Romero, Juan Montoro, Marta Guinot, Luis Almenar, Rafael Andreu, Aitana Balaguer, Isabel Beneyto, Jordi Espí, José Gómez-Codina, Gloria Iacoboni, Isidro Jarque, Rafael López-Andújar, Empar Mayordomo-Aranda, Joaquín Montalar, Amparo Pastor, Miguel Pastor, José L. Piñana, Nohelia Rojas-Ferrer, Ignacio Sánchez-Lázaro, Jesús Sandoval, Guillermo Sanz, Miguel Á. Sanz, Amparo Solé & Jaime Sanz. (2019) Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation. Leukemia & Lymphoma 60:1, pages 142-150.
Read now
Read now
Aizuri Murad, Kieran Sheahan & Brian Kirby. (2018) Primary cutaneous post liver transplant lymphoproliferative disorder (PTLD) successfully treated with radiotherapy. Journal of Dermatological Treatment 29:2, pages 168-169.
Read now
Read now
Olivier Gheysens, Sanne Thielemans, Julie Morscio, Nancy Boeckx, Karolien E. Goffin, Christophe M. Deroose, Xavier Sagaert, Iwona Wlodarska, Gregor Verhoef, Daan Dierickx & Thomas Tousseyn. (2016) Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: 18F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy. Leukemia & Lymphoma 57:10, pages 2382-2388.
Read now
Read now
Javier Segovia & Koen van Besien. (2015) Antithymocyte globulin for graft-versus-host disease prophylaxis: mistakenly maligned. Leukemia & Lymphoma 56:4, pages 841-842.
Read now
Read now
S. Van Peteghem & M. De Pauw. (2015) Cerebral pathology post heart transplantation. Acta Clinica Belgica 70:2, pages 112-115.
Read now
Read now
Articles from other publishers (80)
Asisha M. Janeela, Nambiathayil A. Fouzia & Uday G. Zachariah. (2024) Post-transplantation Lymphoproliferative Disorder (PTLD): In the Liver Transplant Recipient. Journal of Clinical and Experimental Hepatology 14:2, pages 101286.
Crossref
Crossref
Gérard Socié, Pere Barba, Arie Barlev, Jaime Sanz, Irene García-Cadenas, Patrice Chevallier, Franca Fagioli, Norma Guzman-Becerra, Deepali Kumar, Per Ljungman, Arnaud Pigneux, Natalia Sadetsky, Lucrecia Yáñez San Segundo, Mazyar Shadman, Jan Storek, Dhanalakshmi Thirumalai, Baodong Xing & Mohamad Mohty. (2023) Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy. Bone Marrow Transplantation.
Crossref
Crossref
Thomas G. Gross & Jeremy D. Rubinstein. (2023) Post‐transplant lymphoproliferative disease in children, adolescents, and young adults. Hematological Oncology 41:S1, pages 48-56.
Crossref
Crossref
Jeremy Rubinstein, Keri Toner, Thomas Gross & Birte Wistinghausen. (2023) Diagnosis and management of post-transplant lymphoproliferative disease following solid organ transplantation in children, adolescents, and young adults. Best Practice & Research Clinical Haematology 36:1, pages 101446.
Crossref
Crossref
Miruna Cristian, Radu Andrei Baz, Andreea Georgiana Stoica, Mariana Așchie, Maria Mihaela Ghinea, Mariana Deacu, Madalina Boșoteanu, Anca Florentina Mitroi, Nicolae Dobrin, Ionut Eduard Iordache & Gabriela Izabela Bălțătescu. (2023) Diffuse large B cell lymphoma CD5-positive arising in an immune deficiency and immune dysregulation setting: A case report and brief review of the literature. Medicine 102:8, pages e33083.
Crossref
Crossref
Bastian N. Ruijter, Ron WolterbeekMitchell HewMarjolein van Reeven, Danny van der Helm, Jeroen DubbeldMaarten E. TushuizenHerold MetselaarAnn C.T.M. VossenBart van Hoek. (2023) Epstein–Barr Viral Load Monitoring Strategy and the Risk for Posttransplant Lymphoproliferative Disease in Adult Liver Transplantation. Annals of Internal Medicine 176:2, pages 174-181.
Crossref
Crossref
Vibeke K. J. Vergote, Christophe M. Deroose, Steffen Fieuws, Wim Laleman, Ben Sprangers, Anne Uyttebroeck, Johan Van Cleemput, Gregor Verhoef, Robin Vos, Thomas Tousseyn & Daan Dierickx. (2022) Characteristics and Outcome of Post-Transplant Lymphoproliferative Disorders After Solid Organ Transplantation: A Single Center Experience of 196 Patients Over 30 Years. Transplant International 35.
Crossref
Crossref
Kwun Wah Wen, Linlin Wang, Joshua R. Menke & Blossom Damania. (2021) Cancers associated with human gammaherpesviruses. The FEBS Journal 289:24, pages 7631-7669.
Crossref
Crossref
Ryan J. Stubbins, Ryan Lam, James Zhu, Sunita Ghosh, Curtis Mabilangan, John Kuruvilla, Rashmi S Goswami, Raymond Lai, Jutta K Preiksaitis, Michael D Jain & Anthea C Peters. (2022) Tumor Infiltrating Lymphocytes Predict Survival in Solid Organ Transplant Recipients With Monomorphic Post-transplant Lymphoproliferative Disorders. Clinical Lymphoma Myeloma and Leukemia 22:10, pages 744-752.
Crossref
Crossref
Daan Dierickx, Martyna Pociupany & Yaso Natkunam. (2022) Epstein-Barr virus-associated posttransplant lymphoproliferative disorders: new insights in pathogenesis, classification and treatment. Current Opinion in Oncology 34:5, pages 413-421.
Crossref
Crossref
William Reiche, Abubakar Tauseef, Ahmed Sabri, Mohsin Mirza, David Cantu, Peter Silberstein & Saurabh Chandan. (2022) Gastrointestinal manifestations, risk factors, and management in patients with post-transplant lymphoproliferative disorder: A systematic review. World Journal of Transplantation 12:8, pages 268-280.
Crossref
Crossref
Jolanta Malyszko, Grzegorz Basak, Krzysztof Batko, Giavambatista Capasso, Anna Capasso, Joanna Drozd-Sokolowska, Katarzyna Krzanowska, Pawel Kulicki, Joanna Matuszkiewicz-Rowinska, Maria Jose Soler, Ben Sprangers & Jacek Malyszko. (2022) Haematological disorders following kidney transplantation. Nephrology Dialysis Transplantation 37:3, pages 409-420.
Crossref
Crossref
Rabea Asleh, Hilmi Alnsasra, Thomas M. Habermann, Alexandros Briasoulis & Sudhir S. Kushwaha. (2022) Post-transplant Lymphoproliferative Disorder Following Cardiac Transplantation. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Yuko Takeuchi, Jun Ochiai, Osamu Onoda, Morikuni Nishihira, Kazuharu Uchida & Mari Yoshida. (2022) Primary central nervous system post-transplant lymphoproliferative disorder with few specific abnormal findings observed on MRI and in the cerebrospinal fluid多彩な神経症状を呈しMRI・髄液にて特異的な異常所見が検出されなかった中枢神経原発移植後リンパ増殖性疾患の1例. Rinsho Shinkeigaku 62:1, pages 44-48.
Crossref
Crossref
F. Montes de Jesus, D. Dierickx, V. Vergote, W. Noordzij, R. A. J. O. Dierckx, C. M. Deroose, A. W. J. M. Glaudemans, O. Gheysens & T. C. Kwee. (2021) Prognostic superiority of International Prognostic Index over [18F]FDG PET/CT volumetric parameters in post-transplant lymphoproliferative disorder. EJNMMI Research 11:1.
Crossref
Crossref
Stephen Boyle, Joshua W. D. Tobin, Jacinta Perram, Nada Hamad, Veena Gullapalli, Allison Barraclough, Lydia Singaraveloo, Min-Hi Han, Richard Blennerhassett, Niles Nelson, Anna M. Johnston, Dipti Talaulikar, Krishna Karpe, Abir Bhattacharyya, Chan Yoon Cheah, Elango Subramoniapillai, Waqas Bokhari, Cindy Lee, Eliza A. Hawkes, Andrew Jabbour, Simone I. Strasser, Steven J. Chadban, Christina Brown, Peter Mollee & Greg Hapgood. (2021) Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lymphoma Alliance. HemaSphere 5:11, pages e648.
Crossref
Crossref
Rebecca L. King, Arushi Khurana, Raphael Mwangi, Angelo Fama, Kay M. Ristow, Matthew J. Maurer, William R. Macon, Stephen M. Ansell, N. Nora Bennani, Yogish C. Kudva, Randall C. Walker, Kymberly D. Watt, Thomas R. Schwab, Sudhir S. Kushwaha, James R. Cerhan & Thomas M. Habermann. (2021) Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic Criteria. HemaSphere 5:10, pages e640.
Crossref
Crossref
Laura McDonald, Roseann O’ Doherty, Eileen Ryan, Helen Enright, Eoghan Dunlea, Sarah Kelliher, Anne Fortune, Michael Fay, SW Maung, Ronan Desmond, Catherine Wall, Senthil Kumar, Derville O’ Shea, Kamal Fadalla, DG Connaghan & Liam Smyth. (2021) Posttransplant Lymphoproliferative Disorder After Solid Organ Transplant: A Heterogeneous, Aggressive Disorder. Clinical Lymphoma Myeloma and Leukemia 21:10, pages 694-700.
Crossref
Crossref
Anna Füreder, Gabriele Kropshofer, Martin Benesch, Michael Dworzak, Sabine Greil, Wolf‐Dietrich Huber, Holger Hubmann, Anita Lawitschka, Georg Mann, Ina Michel‐Behnke, Thomas Müller‐Sacherer, Herbert Pichler, Ingrid Simonitsch‐Klupp, Wolfgang Schwinger, Zsolt Szepfalusi, Roman Crazzolara & Andishe Attarbaschi. (2021) Characteristics, management, and outcome of pediatric patients with post‐transplant lymphoproliferative disease—A 20 years' experience from Austria. Cancer Reports 4:5.
Crossref
Crossref
Yanmin Zhang, Rachel Mariani, Michelle Gong, Dawn Kirschmann, Edward Caparelli, Nneka Wallace, Rebekah Turner, Xinyan Lu, Juehua Gao, Kai Lee Yap & Shunyou Gong. (2021) Distinctive Clinicopathologic Features of Monomorphic B-cell Post-transplant Lymphoproliferative Disorders in Children. Pediatric and Developmental Pathology 24:4, pages 318-326.
Crossref
Crossref
Ben Sprangers, Leonardo V. Riella & Daan Dierickx. (2021) Posttransplant Lymphoproliferative Disorder Following Kidney Transplantation: A Review. American Journal of Kidney Diseases 78:2, pages 272-281.
Crossref
Crossref
Tetsuya Tajima, Koichiro Hata, Hironori Haga, Momoko Nishikori, Katsutsugu Umeda, Jiro Kusakabe, Hidetaka Miyauchi, Tatsuya Okamoto, Eri Ogawa, Mari Sonoda, Hidefumi Hiramatsu, Masakazu Fujimoto, Hideaki Okajima, Junko Takita, Akifumi Takaori‐Kondo & Shinji Uemoto. (2021) Post‐transplant Lymphoproliferative Disorders After Liver Transplantation: A Retrospective Cohort Study Including 1954 Transplants. Liver Transplantation 27:8, pages 1165-1180.
Crossref
Crossref
Hong Song, Kip E. Guja & Andrei Iagaru. (2021) 18F-FDG PET/CT for Evaluation of Post-Transplant Lymphoproliferative Disorder (PTLD). Seminars in Nuclear Medicine 51:4, pages 392-403.
Crossref
Crossref
Regina M. Plummer, Michael A. Linden & Amy K. Beckman. (2021) Update on B-cell lymphoproliferative disorders of the gastrointestinal tract. Seminars in Diagnostic Pathology 38:4, pages 14-20.
Crossref
Crossref
Hideaki Saito, Hiroaki Miyoshi, Hirohiko Shibayama, Jun Toda, Shinsuke Kusakabe, Michiko Ichii, Jiro Fujita, Kentaro Fukushima, Tetsuo Maeda, Masao Mizuki, Kenji Oritani, Masao Seto, Takafumi Yokota, Yuzuru Kanakura, Naoki Hosen & Koichi Ohshima. (2021) High numbers of programmed cell death-1-positive tumor infiltrating lymphocytes correlate with early onset of post-transplant lymphoproliferative disorder. International Journal of Hematology 114:1, pages 53-64.
Crossref
Crossref
Mathis Overkamp, Massimo Granai, Irina Bonzheim, Julia Steinhilber, Jens Schittenhelm, Wolfgang Bethge, Leticia Quintanilla-Martinez, Falko Fend & Birgit Federmann. (2020) Comparative analysis of post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation reveals differences in the tumor microenvironment. Virchows Archiv 478:6, pages 1135-1148.
Crossref
Crossref
Mi-Rin Lee, Jae-Do Yang & Hee-Chul Yu. (2021) Successful treatment of the Epstein-Barr virus-negative post-transplant lymphoproliferative disorder, Ann Anbor stage IVB, using R-CHOP: a case report. Annals of Liver Transplantation 1:1, pages 95-99.
Crossref
Crossref
Leah A. Cardwell, Jacquelyn Majerowski, Yvonne E. Chiu, Alexandra M. Harrington & Olayemi Sokumbi. (2021)
Post‐transplant
primary cutaneous peripheral
T‐cell
lymphoma not otherwise specified in a pediatric patient
. Journal of Cutaneous Pathology 48:5, pages 706-712.
Crossref
Crossref
Nimish Shah, Toby A. Eyre, David Tucker, Shireen Kassam, Jasvir Parmar, Carrie Featherstone, Peter Andrews, Elham Asgari, Sridhar Chaganti, Tobias F. Menne, Christopher P. Fox, Stephen Pettit, Abid Suddle & Kristian M. Bowles. (2021) Front‐line management of post‐transplantation lymphoproliferative disorder in adult solid organ recipient patients — A British Society for Haematology Guideline. British Journal of Haematology 193:4, pages 727-740.
Crossref
Crossref
Cecilia Nakid-Cordero, Marine Baron, Amélie Guihot & Vincent Vieillard. (2021) Natural Killer Cells in Post-Transplant Lymphoproliferative Disorders. Cancers 13:8, pages 1836.
Crossref
Crossref
Francesco Pegoraro & Claudio Favre. (2021) Post-transplantation lymphoproliferative disorder after haematopoietic stem cell transplantation. Annals of Hematology 100:4, pages 865-878.
Crossref
Crossref
Eric Lau, Justin Tyler Moyers, Billy Chen Wang, Il Seok Daniel Jeong, Joanne Lee, Lawrence Liu, Matthew Kim, Rafael Villicana, Bobae Kim, Jasmine Mitchell, Muhammed Omair Kamal, Chien-Shing Chen, Yan Liu, Jun Wang, Richard Chinnock & Huynh Cao. (2021) Analysis of Post-Transplant Lymphoproliferative Disorder (PTLD) Outcomes with Epstein–Barr Virus (EBV) Assessments—A Single Tertiary Referral Center Experience and Review of Literature. Cancers 13:4, pages 899.
Crossref
Crossref
Napat Leeaphorn, Charat Thongprayoon, Api Chewcharat, Panupong Hansrivijit, Caroline C. Jadlowiec, Lee S. Cummings, Sreelatha Katari, Shennen A. Mao, Michael A. Mao & Wisit Cheungpasitporn. (2020) Outcomes of kidney retransplantation in recipients with prior posttransplant lymphoproliferative disorders: An analysis of the 2000–2019 UNOS/OPTN database. American Journal of Transplantation 21:2, pages 846-853.
Crossref
Crossref
Naosuke Yokoyama, Takamichi Kanbayashi, Shunsuke Kobayashi, Tsuyoshi Ishida & Masahiro Sonoo. (2021) Subacute cognitive impairment and urinary retention due to primary central nervous system post-transplant lymphoproliferative disorder: a case report亜急性の認知機能低下と尿閉で発症した中枢神経原発移植後リンパ増殖性疾患の1例. Rinsho Shinkeigaku 61:11, pages 750-755.
Crossref
Crossref
Upton D. Allen & Daan Dierickx. 2021. Post-Transplant Lymphoproliferative Disorders. Post-Transplant Lymphoproliferative Disorders
129
148
.
Rebecca J. Leeman-Neill, Craig R. Soderquist, Francesca Montanari, Patricia Raciti, David Park, Dejan Radeski, Mahesh M. Mansukhani, Vundavalli V. Murty, Susan Hsiao, Bachir Alobeid & Govind Bhagat. (2020) Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. Haematologica 107:1, pages 201-210.
Crossref
Crossref
Yusuke Kajimoto, Yasuhiro Terasaki, Mika Terasaki, Shinobu Kunugi, Yugo Okabe, Satoshi Wakita, Koiti Inokuchi & Akira Shimizu. (2020) T-cell lymphoma with a granulomatous lesion of the lungs after autologous hematopoietic stem cell transplantation for Epstein–Barr virus-positive diffuse large B-cell lymphoma: a unique rare case of metachronous B-cell and T-cell lymphoma. Diagnostic Pathology 15:1.
Crossref
Crossref
David M. Burns, Katherine Clesham, Yan A. Hodgson, Lynsey Fredrick, Joanna Haughton, Michelle Lannon, Hayder Hussein, Jin-Sup Shin, Robert J. Hollows, Lisa Robinson, Catherine Byrne, Christopher McNamara, Bindu Vydianath, Anne L. Lennard, Paul Fields, Rod Johnson, Josh Wright, Christopher P. Fox, Kate Cwynarski & Sridhar Chaganti. (2020) Real-world Outcomes With Rituximab-based Therapy for Posttransplant Lymphoproliferative Disease Arising After Solid Organ Transplant. Transplantation 104:12, pages 2582-2590.
Crossref
Crossref
Kenneth Ofori, Craig R. Soderquist, Vundavalli V. Murty, David Park, George Vlad, Rebecca J. Leeman‐Neill, Suzanne Lentzsch, Bachir Alobeid & Govind Bhagat. (2020) The clinical and pathological features of plasma cell myeloma post solid organ transplantation. American Journal of Hematology 95:12, pages 1531-1541.
Crossref
Crossref
Anna Christina Dragon, Katharina Zimmermann, Thomas Nerreter, Deborah Sandfort, Julia Lahrberg, Stephan Klöß, Christina Kloth, Caroline Mangare, Agnes Bonifacius, Sabine Tischer-Zimmermann, Rainer Blasczyk, Britta Maecker-Kolhoff, Barbara Uchanska-Ziegler, Hinrich Abken, Axel Schambach, Michael Hudecek & Britta Eiz-Vesper. (2020) CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation. Journal for ImmunoTherapy of Cancer 8:2, pages e000736.
Crossref
Crossref
Michael D. Jain, Ryan Lam, Zhihui Liu, Ryan J. Stubbins, Amrit Kahlon, Roopesh Kansara, Rashmi Goswami, Atul Humar, Anca Prica, Laurie H. Sehn, Graham W. Slack, Michael Crump, Kerry J. Savage, Anthea C. Peters & John Kuruvilla. (2020) Failure of rituximab is associated with a poor outcome in diffuse large B cell lymphoma‐type post‐transplant lymphoproliferative disorder. British Journal of Haematology 189:1, pages 97-105.
Crossref
Crossref
H A Noureldine, W Nour-Eldine, M H Hodroj, M H A Noureldine, A Taher & I Uthman. (2020) Hematological malignancies in connective tissue diseases. Lupus 29:3, pages 225-235.
Crossref
Crossref
F. M. Montes de Jesus, T. C. Kwee, X. U. Kahle, M. Nijland, T. van Meerten, G. Huls, R. A. J. O. Dierckx, S. Rosati, A. Diepstra, W. van der Bij, E. A. M. Verschuuren, A. W. J. M. Glaudemans & W. Noordzij. (2019) Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield. European Journal of Nuclear Medicine and Molecular Imaging 47:3, pages 529-536.
Crossref
Crossref
Fedaey Abbas, Mohsen El Kossi, Ihab Sakr Shaheen, Ajay Sharma & Ahmed Halawa. (2020) Post-transplantation lymphoproliferative disorders: Current concepts and future therapeutic approaches. World Journal of Transplantation 10:2, pages 29-46.
Crossref
Crossref
Ayumi Fujimoto & Ritsuro Suzuki. (2020) Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorders after Hematopoietic Stem Cell Transplantation: Pathogenesis, Risk Factors and Clinical Outcomes. Cancers 12:2, pages 328.
Crossref
Crossref
L. Carmans, A. Van Craenenbroeck, K. Lagrou, C.M. Deroose, X. Sagaert, A. Wolthuis, E. Van Wijngaerden & D.R. Kuypers. (2020) Disseminated histoplasmosis in a kidney liver transplant patient from a non-endemic area: A diagnostic challenge. IDCases 22, pages e00971.
Crossref
Crossref
Hong Beum Kim, Ran Hong, Yung Sub Na, Woo Young Choi, Sang Gon Park & Hee Jeong Lee. (2019) Isolated peritoneal lymphomatosis defined as post-transplant lymphoproliferative disorder after a liver transplant: A case report. World Journal of Clinical Cases 7:24, pages 4299-4306.
Crossref
Crossref
Eren ARSLAN DAVULCU, Hale BÜLBÜL, Yusuf ULUSOY, Nur Akad SOYER, Derya DEMİR, Nazan ÖZSAN, Güneş AK, Fahri ŞAHİN, Mahmut TÖBÜ, Murat TOMBULOĞLU, Filiz VURAL & Güray SAYDAM. (2019) Solid Organ Transplantasyonu Sonrası Post-Transplant Lenfoproliferatif Hastalıklar: Tek Merkez Deneyimi. Dicle Tıp Dergisi 46:4, pages 743-749.
Crossref
Crossref
Amit Azriel, James E. Towner, Frank Gaillard, Georgia Box, TeWhiti Rogers & Andrew Morokoff. (2019) Solitary intraventricular Hodgkin lymphoma post-transplant lymphoproliferative disease (HL-PTLD): Case report. Journal of Clinical Neuroscience 69, pages 269-272.
Crossref
Crossref
Arnaud G. L’Huillier, Anne I. Dipchand, Vicky L. Ng, Diane Hebert, Yaron Avitzur, Melinda Solomon, Bo-Yee Ngan, Derek Stephens, Angela S. Punnett, Michelle Barton & Upton D. Allen. (2019) Posttransplant lymphoproliferative disorder in pediatric patients: Survival rates according to primary sites of occurrence and a proposed clinical categorization. American Journal of Transplantation 19:10, pages 2764-2774.
Crossref
Crossref
Michelle H. Lee, Emily Wilding & Jennie Y. Law. (2019) A New Brain Mass in an Immunocompromised Woman. JAMA Oncology 5:8, pages 1217.
Crossref
Crossref
Lukas Marcelis & Thomas Tousseyn. (2019) The Tumor Microenvironment in Post-Transplant Lymphoproliferative Disorders. Cancer Microenvironment 12:1, pages 3-16.
Crossref
Crossref
Jennifer L. Crombie & Ann S. LaCasce. (2019) Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders. Frontiers in Oncology 9.
Crossref
Crossref
Jakapat Vanichanan, Suwasin Udomkarnjananun, Yingyos Avihingsanon & Kamonwan Jutivorakool. (2018) Common viral infections in kidney transplant recipients. Kidney Research and Clinical Practice 37:4, pages 323-337.
Crossref
Crossref
E. ProkopenkoE. Shcherbakova. (2018) POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS IN PATIENTS WITH KIDNEY ALLOGRAFT. Nephrology (Saint-Petersburg) 22:6, pages 77-83.
Crossref
Crossref
S. Bobillo, P. Abrisqueta, B. Sánchez-González, E. Giné, S. Romero, M. Alcoceba, E. González-Barca, S. González de Villambrosía, J. M. Sancho, P. Gómez, L. Bento, J. Montoro, S. Montes, A. López & F. Bosch. (2018) Posttransplant monomorphic Burkitt’s lymphoma: clinical characteristics and outcome of a multicenter series. Annals of Hematology 97:12, pages 2417-2424.
Crossref
Crossref
Lukas Marcelis, Charlien Berghen, Alexandra De Zutter, Pauline Biesemans, Peter Vandenberghe, Gregor Verhoef, Olivier Gheysens, Xavier Sagaert, Daan Dierickx & Thomas Tousseyn. (2018) Other immunomodulatory agent-related lymphoproliferative diseases: a single-center series of 72 biopsy-confirmed cases. Modern Pathology 31:9, pages 1457-1469.
Crossref
Crossref
Ajay Major & Manali Kamdar. (2018) Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder. Current Treatment Options in Oncology 19:7.
Crossref
Crossref
. Experimental and Clinical Transplantation 16:3.
Crossref
Crossref
Daan DierickxThomas M. Habermann. (2018) Post-Transplantation Lymphoproliferative Disorders in Adults. New England Journal of Medicine 378:6, pages 549-562.
Crossref
Crossref
Rohit Bishnoi, Ravneet Bajwa, Aaron J. Franke, William Paul SkeltonIVIV, Yu Wang, Niraj M. Patel, William Birdsall Slayton, Fei Zou & Nam H. Dang. (2017) Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients. Experimental Hematology & Oncology 6:1.
Crossref
Crossref
Dennis D. Weisenburger & Thomas G. Gross. (2017) Post-transplant lymphoproliferative disorder: a heterogeneous conundrum. British Journal of Haematology 179:5, pages 854-856.
Crossref
Crossref
Li Fu, Jianlan Xie, Jun Lin, Jingshi Wang, Na Wei, Dayong Huang, Tingting Wang, Jing Shen, Xiaoge Zhou & Zhao Wang. (2017) Monomorphic Post-transplant Lymphoproliferative Disorder After Kidney Transplantation and Hematopoietic Stem Cell Transplantation: Clinicopathological Characteristics, Treatments and Prognostic Factors. Indian Journal of Hematology and Blood Transfusion 33:4, pages 492-499.
Crossref
Crossref
Zhi-Yuan Qiu, Guang-Yu Tian, Zhao Zhang, Ye-Qing Zhang, Wei Xu & Jian-Yong Li. (2017) Large granular lymphocytosis after transplantation. Oncotarget 8:46, pages 81697-81708.
Crossref
Crossref
A. Malone, G. Kennedy, L. Storey, A. O?Marcaigh, M. McDermott, A. M. Broderick & O. P. Smith. (2016) Post-transplant lymphoproliferative disorder in paediatric patients: the Irish perspective?a single centre experience. Irish Journal of Medical Science (1971 -) 186:2, pages 339-343.
Crossref
Crossref
Julie Morscio, Julio Finalet Ferreiro, Sara Vander Borght, Emilie Bittoun, Olivier Gheysens, Daan Dierickx, Gregor Verhoef, Iwona Wlodarska & Thomas Tousseyn. (2017) Identification of distinct subgroups of EBV-positive post-transplant diffuse large B-cell lymphoma. Modern Pathology 30:3, pages 370-381.
Crossref
Crossref
Reuben J. Arasaratnam & Alejandro Restrepo. (2017) Posttransplant Lymphoproliferative Disease Presenting as an Extracranial Mass. Case Reports in Transplantation 2017, pages 1-5.
Crossref
Crossref
Man Law, Hay Chan, Ho Lai, Chung Ha, Celia Ng, Yiu Yeung & Sze Yip. (2016) Post‑transplant lymphoproliferative disorder presenting with skin ulceration in a renal transplant recipient who achieved sustained remission with rituximab therapy: A case report. Molecular and Clinical Oncology.
Crossref
Crossref
Tracy T. BatchelorLim Soon ThyeThomas M. Habermann. (2016) Current Management Concepts: Primary Central Nervous System Lymphoma, Natural Killer T-Cell Lymphoma Nasal Type, and Post-transplant Lymphoproliferative Disorder. American Society of Clinical Oncology Educational Book:36, pages e354-e366.
Crossref
Crossref
Daan DierickxThomas Tousseyn & Olivier Gheysens. (2015) How I treat posttransplant lymphoproliferative disorders. Blood 126:20, pages 2274-2283.
Crossref
Crossref
M.R. Luskin, D.S. Heil, K.S. Tan, S. Choi, E.A. Stadtmauer, S.J. Schuster, D.L. Porter, R.H. Vonderheide, A. Bagg, D.F. Heitjan, D.E. Tsai & R. Reshef. (2015) The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder. American Journal of Transplantation 15:10, pages 2665-2673.
Crossref
Crossref
Nathalie Berghen, Laure-Anne Teuwen, Rene Westhovens & Patrick Verschueren. (2015) Malignancies and anti-TNF therapy in rheumatoid arthritis: a single-center observational cohort study. Clinical Rheumatology 34:10, pages 1687-1695.
Crossref
Crossref
R.U. Trappe, S. Choquet, D. Dierickx, P. Mollee, J.M. Zaucha, M.H. Dreyling, U. Dührsen, C. Tarella, O. Shpilberg, M. Sender, G. Salles, F. Morschhauser, A. Jaccard, T. Lamy, P. Reinke, R. Neuhaus, H. Lehmkuhl, H.A. Horst, M. Leithäuser, P. Schlattmann, I. Anagnostopoulos, M. Raphael, H. Riess, V. Leblond & S. Oertel. (2015) International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20-Positive B Cell PTLD: Clues From the PTLD-1 Trial. American Journal of Transplantation 15:4, pages 1091-1100.
Crossref
Crossref
Daan Dierickx. (2015) Posttransplant lymphoproliferative disorders following liver transplantation: Where are we now?. World Journal of Gastroenterology 21:39, pages 11034.
Crossref
Crossref
Blanca Gonzalez-Farre, Jordina Rovira, Daniel Martinez, Alexandra Valera, Adriana Garcia-Herrera, Maria Angeles Marcos, Carla Sole, Gael Roue, Dolors Colomer, Elena Gonzalvo, Imma Ribera-Cortada, Monica Araya, Josep Lloreta, Luis Colomo, Elias Campo, Armando Lopez-Guillermo & Antonio Martinez. (2014) In vivo intratumoral Epstein–Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications. Modern Pathology 27:12, pages 1599-1611.
Crossref
Crossref
Young-Uk ChoHyun-Sook ChiSeongsoo JangSang Hyuk ParkChan-Jeoung Park. (2014) Pattern Analysis of Epstein-Barr Virus Viremia and Its Significance in the Evaluation of Organ Transplant Patients Suspected of Having Posttransplant Lymphoproliferative Disorders. American Journal of Clinical Pathology 141:2, pages 268-274.
Crossref
Crossref
Frederick D. Grant. 2014. Pediatric Nuclear Medicine and Molecular Imaging. Pediatric Nuclear Medicine and Molecular Imaging
479
496
.
Daan Dierickx, Thomas Tousseyn, Julie Morscio, Steffen Fieuws & Gregor Verhoef. (2013) Validation of Prognostic Scores in Post-Transplantation Lymphoproliferative Disorders. Journal of Clinical Oncology 31:27, pages 3443-3444.
Crossref
Crossref
J. Morscio, D. Dierickx, J.F. Ferreiro, A. Herreman, P. Van Loo, E. Bittoun, G. Verhoef, P. Matthys, J. Cools, I. Wlodarska, C. De Wolf-Peeters, X. Sagaert & T. Tousseyn. (2013) Gene Expression Profiling Reveals Clear Differences Between EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders. American Journal of Transplantation 13:5, pages 1305-1316.
Crossref
Crossref
J. Morscio, D. Dierickx & T. Tousseyn. (2013) Molecular Pathogenesis of B-Cell Posttransplant Lymphoproliferative Disorder: What Do We Know So Far?. Clinical and Developmental Immunology 2013, pages 1-13.
Crossref
Crossref